[HTML][HTML] The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy

B Boersma, W Jiskoot, P Lowe, C Bourquin - Cytokine & growth factor …, 2021 - Elsevier
Abstract The interleukin-1 (IL-1) family is one of the first described cytokine families and
consists of eight cytokines (IL-1β, IL-1α, IL-18, IL-33, IL-36α, IL-36β, IL-36γ and IL-37) and …

[HTML][HTML] The pro-and anti-inflammatory properties of the cytokine interleukin-6

J Scheller, A Chalaris, D Schmidt-Arras… - Biochimica et Biophysica …, 2011 - Elsevier
Interleukin-6 is a cytokine not only involved in inflammation and infection responses but also
in the regulation of metabolic, regenerative, and neural processes. In classic signaling …

IL-6 receptor and mechanism of signal transduction

T Kishimoto, S Akira, T Taga - International journal of …, 1992 - Elsevier
Abstract Interleukin-6 (IL-6) is a multifunctional cytokine which acts on a wide variety of cells,
exerting growth promotion, growth inhibition, or specific gene expression including cellular …

No inhibition of IL-27 signaling by soluble gp130

J Scheller, B Schuster, C Hölscher, T Yoshimoto… - Biochemical and …, 2005 - Elsevier
Soluble gp130 is the natural inhibitor of trans-signaling mediated by the soluble IL-6/IL-6R
complex. In mouse models, recombinant sgp130 has been successfully applied for the …

IL-6 as a drug discovery target

B Stein, MSK Sutherland - Drug Discovery Today, 1998 - Elsevier
Interleukin 6 (IL-6) is a cytokine that functions as a trophic and differentiating factor in cells of
many types. Because of its wide-ranging expression and effects, the inappropriate …

A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth

JL Su, KP Lai, CA Chen, CY Yang, PS Chen… - Cancer research, 2005 - AACR
Experimental and clinical findings support the essential role of interleukin (IL)-6 in the
pathogenesis of various human cancers and provide a rationale for targeted therapeutic …

[HTML][HTML] Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

SA Jones, J Scheller… - The Journal of clinical …, 2011 - Am Soc Clin Investig
The successful treatment of certain autoimmune conditions with the humanized anti–IL-6
receptor (IL-6R) antibody tocilizumab has emphasized the clinical importance of cytokines …

Biological effects of interleukin-6: clinical applications in autoimmune diseases and cancers

LJ Ho, SF Luo, JH Lai - Biochemical pharmacology, 2015 - Elsevier
Abstract Interleukin-6 (IL-6) is a pro-inflammatory cytokine involved in the pathogenesis of
various autoimmune and chronic inflammatory diseases. Binding of IL-6 to its receptor (IL …

Role of interleukin-6 in cancer progression and therapeutic resistance

N Kumari, BS Dwarakanath, A Das, AN Bhatt - Tumor Biology, 2016 - Springer
In the last several decades, the number of people dying from cancer-related deaths has not
reduced significantly despite phenomenal advances in the technologies related to diagnosis …

[HTML][HTML] Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases

T Tanaka, T Kishimoto - International journal of biological sciences, 2012 - ncbi.nlm.nih.gov
Abstract Interleukin (IL)-6, a cytokine featuring redundancy and pleiotropic activity,
contributes to host defense against acute environmental stress, while dysregulated …